Galera Therapeutics, Inc.

NasdaqGM:GRTX Stock Report

Market Cap: US$10.1m

Galera Therapeutics Balance Sheet Health

Financial Health criteria checks 0/6

Galera Therapeutics has a total shareholder equity of $-131.2M and total debt of $151.0M, which brings its debt-to-equity ratio to -115.1%. Its total assets and total liabilities are $26.1M and $157.3M respectively.

Key information

-115.1%

Debt to equity ratio

US$151.05m

Debt

Interest coverage ration/a
CashUS$18.26m
Equity-US$131.18m
Total liabilitiesUS$157.33m
Total assetsUS$26.14m

Recent financial health updates

Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Feb 15
Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Oct 25
Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Recent updates

Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Feb 15
Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Oct 25
Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Galera Therapeutics appoints chief medical officer

Sep 01

Galera down ~8% after phase 1 data for non-small cell lung cancer combination treatment

Jun 29

Companies Like Galera Therapeutics (NASDAQ:GRTX) Could Be Quite Risky

Jun 15
Companies Like Galera Therapeutics (NASDAQ:GRTX) Could Be Quite Risky

Is Galera Therapeutics Stock A Buy, Sell, Or Hold? Several Catalysts To Watch In 2022

Mar 23

Here's Why We're A Bit Worried About Galera Therapeutics' (NASDAQ:GRTX) Cash Burn Situation

Feb 24
Here's Why We're A Bit Worried About Galera Therapeutics' (NASDAQ:GRTX) Cash Burn Situation

Galera Therapeutics: Trial Reversal Did Not Take The Stock Higher

Dec 24

Companies Like Galera Therapeutics (NASDAQ:GRTX) Could Be Quite Risky

Nov 04
Companies Like Galera Therapeutics (NASDAQ:GRTX) Could Be Quite Risky

Will Galera Therapeutics (NASDAQ:GRTX) Spend Its Cash Wisely?

Aug 05
Will Galera Therapeutics (NASDAQ:GRTX) Spend Its Cash Wisely?

Here's Why We're Watching Galera Therapeutics' (NASDAQ:GRTX) Cash Burn Situation

Feb 17
Here's Why We're Watching Galera Therapeutics' (NASDAQ:GRTX) Cash Burn Situation

Galera Therapeutics EPS beats by $0.08

Nov 10

Financial Position Analysis

Short Term Liabilities: GRTX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: GRTX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: GRTX has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: GRTX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: GRTX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: GRTX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.9% each year


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.